Fulgent Genetics Inc (FLGT)

Current ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total current assets US$ in thousands 353,571 326,539 399,104 386,509 507,845 549,855 528,289 914,867 905,632 1,022,160 675,185 1,238,560 1,074,460 622,836 925,615 659,140 615,726 194,650 16,294 76,995
Total current liabilities US$ in thousands 72,899 73,990 75,751 75,949 73,018 61,421 64,819 107,848 116,178 124,385 127,527 152,630 112,840 147,158 129,130 196,530 131,074 60,356 8,872 7,953
Current ratio 4.85 4.41 5.27 5.09 6.96 8.95 8.15 8.48 7.80 8.22 5.29 8.11 9.52 4.23 7.17 3.35 4.70 3.23 1.84 9.68

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $353,571K ÷ $72,899K
= 4.85

Fulgent Genetics Inc's current ratio has shown fluctuations over the past few years, indicating changes in its short-term liquidity position. The current ratio compares a company's current assets to its current liabilities, reflecting its ability to meet short-term obligations.

As of December 31, 2024, Fulgent Genetics Inc's current ratio was 4.85, suggesting that the company had $4.85 in current assets for every dollar of current liabilities. This indicates a reasonable liquidity position, as the company has a comfortable buffer to cover its short-term debts.

It is worth noting that the current ratio has varied significantly over the reporting periods, ranging from a low of 1.84 on June 30, 2020, to a high of 9.68 on March 31, 2020. Such fluctuations may be indicative of changes in the company's working capital management, business operations, or financial position.

Overall, Fulgent Genetics Inc's current ratio has generally been above 1, indicating that the company has had sufficient current assets to meet its short-term obligations. However, investors and stakeholders should continue to monitor trends in the current ratio to assess the company's ongoing liquidity position and financial health.